Genetic testing company 23andMe wants to use the vast amounts of genetic data it has gathered over the last few years to start making drugs, according to Bloomberg . Instead of focusing on screening people for various diseases, the company plans to make therapeutic agents that will target these diseases and possibly cure them. It's a pretty big departure for the company that failed to get FDA approval for its DNA testing kit and that only just received FDA clearance to sell a test that looks for markers of Bloom Syndrome, a rare genetic condition that's associated with sun sensitivity and increased cancer risk.
via The Verge - All Posts http://ift.tt/1L1Rbj2
No comments:
Post a Comment